Bottom Line On Trump’s Plan To Target Rebates: Most People’s Costs Will Go Up Slightly, But Patients On Pricey Drugs Will Get Relief

The New York Times takes a look at who will benefit from President Donald Trump's new proposal to go after the complicated drug rebate system that flourishes between drugmakers and pharmacy benefit managers.

from Kaiser Health News http://bit.ly/2DUPFQZ